Actively Recruiting
Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
Led by Rhaeos, Inc. · Updated on 2025-06-06
10
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.
CONDITIONS
Official Title
Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled to receive an infusion therapy of at least 30 minutes in length
- Region of intact skin proximal to the infusion catheter insertion site that is appropriate in size for application of the study device
- Signed informed consent
- Available for 15 minutes of post-measurement monitoring following removal of the study device
You will not qualify if you...
- Patient is under 12 years of age
- Patient-reported history of serious adverse skin reactions to silicone-based adhesives or Tegaderm
- Use of the study device would interfere with standard patient care that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
- Investigator judges that the intravenous
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Infusacare
Skokie, Illinois, United States, 60076
Actively Recruiting
Research Team
A
Anna Somera
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here